- Home
- GRABW vs SRPT Comparison
GRABW vs SRPT Comparison
Compare GRABW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRABW
- SRPT
- Stock Information
- Founded
- GRABW 2012
- SRPT 1980
- Country
- GRABW Singapore
- SRPT United States
- Employees
- GRABW 11267
- SRPT N/A
- Industry
- GRABW Business Services
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- GRABW Consumer Discretionary
- SRPT Health Care
- Exchange
- GRABW Nasdaq
- SRPT Nasdaq
- Market Cap
- GRABW N/A
- SRPT 2.0B
- IPO Year
- GRABW N/A
- SRPT 1997
- Fundamental
- Price
- GRABW $0.49
- SRPT $17.06
- Analyst Decision
- GRABW
- SRPT Hold
- Analyst Count
- GRABW 0
- SRPT 31
- Target Price
- GRABW N/A
- SRPT $40.61
- AVG Volume (30 Days)
- GRABW 54.7K
- SRPT 7.8M
- Earning Date
- GRABW 02-21-2025
- SRPT 11-05-2025
- Dividend Yield
- GRABW N/A
- SRPT N/A
- EPS Growth
- GRABW N/A
- SRPT N/A
- EPS
- GRABW N/A
- SRPT N/A
- Revenue
- GRABW $2,686,000,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- GRABW N/A
- SRPT $10.78
- Revenue Next Year
- GRABW N/A
- SRPT N/A
- P/E Ratio
- GRABW N/A
- SRPT N/A
- Revenue Growth
- GRABW 21.65
- SRPT 64.89
- 52 Week Low
- GRABW $0.15
- SRPT $10.42
- 52 Week High
- GRABW $0.59
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- GRABW 66.31
- SRPT 42.77
- Support Level
- GRABW $0.43
- SRPT $16.85
- Resistance Level
- GRABW $0.55
- SRPT $18.84
- Average True Range (ATR)
- GRABW 0.05
- SRPT 0.99
- MACD
- GRABW 0.02
- SRPT -0.10
- Stochastic Oscillator
- GRABW 69.54
- SRPT 7.55
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.